AL
TXMD icon

Arnhold LLC’s TherapeuticsMD TXMD Stock Holding History

Arnhold LLC’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,000
Closed -$19K – 158
2022
Q1 		$19K Buy
1,000
+500
+100% +$7.86K ﹤0.01% 136
2021
Q4 		$9K Hold
500
– – ﹤0.01% 132
2021
Q3 		$19K Hold
500
– – ﹤0.01% 135
2021
Q2 		$30K Buy
500
+200
+67% +$12.1K ﹤0.01% 130
2021
Q1 		$20K Hold
300
– – ﹤0.01% 134
2020
Q4 		$18K Buy
+300
New +$20.5K ﹤0.01% 138

Other funds holding TXMD

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Arnhold LLC's TXMD Position: Q2 2022 in Review

Arnhold LLC sold out of TherapeuticsMD (TXMD) in Q2 2022, closing a stake of 1,000 shares — an estimated $19K sold.

Arnhold LLC first reported a position in TXMD in Q4 2020 and held it in 6 quarters. The position peaked at $30K in Q2 2021. 53 funds tracked by Wall St. Rank hold TXMD as of Q2 2022.

  • Arnhold LLC reported no remaining TherapeuticsMD position as of Q2 2022 after selling out during the quarter.
  • Arnhold LLC sold 1,000 TherapeuticsMD shares in Q2 2022, an estimated $19K.
  • Arnhold LLC first reported a position in TherapeuticsMD in Q4 2020 and held it in 6 quarters.
  • Arnhold LLC's TherapeuticsMD position peaked at $30K in Q2 2021.
  • 53 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2022.

Based on Arnhold LLC's 13F filing for Q2 2022, filed 26 Jul 2022.